EUROLAB
iso-21149-enumeration-of-aerobic-mesophilic-bacteria-in-cosmetic-and-pharma
Pharmaceutical Microbiology Testing ICH Q10 Pharmaceutical Quality System and Microbial ControlsICH Q6A Testing for Microbiological Attributes of Drug SubstancesICH Q7 GMP Guidelines for Microbial Control in APIsICH Q9 Risk-Based Approach to Microbial ContaminationISO 11737-1 Bioburden Testing for Medical Devices and Pharmaceutical PackagingISO 11737-2 Sterility Assurance and Validation for Pharmaceutical ComponentsISO 11930 Preservation Efficacy Testing for Topical PharmaceuticalsISO 14644-1 Cleanroom Classification for Pharmaceutical ManufacturingISO 14698-1 Biocontamination Control in CleanroomsISO 16212 Yeast and Mold Testing in Pharmaceutical Raw MaterialsISO 18415 Detection of Pathogenic Microorganisms in Non-Sterile ProductsJP XVII Bacterial Endotoxin Test for Injectable PharmaceuticalsJP XVII Microbial Limit Tests for Oral PreparationsJP XVII Sterility Test for Pharmaceutical ProductsPh. Eur. 2.6.1 Sterility Testing for Finished Pharmaceutical ProductsPh. Eur. 2.6.11 Detection of Pathogens in Veterinary PharmaceuticalsPh. Eur. 2.6.12 Microbial Contamination Testing of Non-Sterile ProductsPh. Eur. 2.6.13 Detection of Clostridia in Parenteral SolutionsPh. Eur. 2.6.14 Bacterial Endotoxins – Gel Clot MethodPh. Eur. 2.6.15 Test for Pseudomonas aeruginosa in Topical DrugsPh. Eur. 2.6.16 Test for Staphylococcus aureus in Creams and GelsPh. Eur. 2.6.2 Mycoplasma Detection in Cell-Based PharmaceuticalsPh. Eur. 2.6.25 Testing for Anaerobic Bacteria in Sterile ProductsPh. Eur. 2.6.27 Bacterial Endotoxin Testing in Parenteral DrugsPh. Eur. 2.6.30 Monitoring of Controlled EnvironmentsPh. Eur. 2.6.32 Control of Bacterial Contamination in Ophthalmic DrugsPh. Eur. 2.6.7 Mycobacteria Detection in BiopharmaceuticalsPh. Eur. 2.6.9 Test for Escherichia coli in Non-Sterile PharmaPh. Eur. 5.1.4 Microbiological Quality of Pharmaceutical PreparationsPh. Eur. 5.1.6 Alternative Methods for Microbiological Quality ControlPh. Eur. 5.1.8 Bioburden Limits in Parenteral ManufacturingUSP <1072> Disinfectants and Antiseptics Microbial Efficacy TestUSP <1111> Microbiological Examination of Non-Sterile ProductsUSP <1115> Bioburden Control of Non-Sterile Drug SubstancesUSP <1116> Microbiological Control of Clean Rooms and Controlled EnvironmentsUSP <1117> Microbial Best Practices for Pharmaceutical Lab PersonnelUSP <1207> Package Integrity Evaluation – Microbial Ingress TestUSP <1208> Integrity Testing for Sterile Barrier SystemsUSP <1223> Water Activity Determination in Drug ProductsUSP <1227> Validation of Microbial Recovery MethodsUSP <1229> Microbial Quality of Compendial Water SystemsUSP <1231> Water for Pharmaceutical Purposes – Microbiological TestingUSP <39> Bioburden Limit Testing for Bulk Active IngredientsUSP <39> Microbiological Quality of Compounding PharmaciesUSP <51> Preservative Effectiveness Testing of Multi-Dose PharmaceuticalsUSP <55> Biological Indicators for Sterilization ValidationUSP <61> Microbial Enumeration Tests for Raw Pharmaceutical MaterialsUSP <61>/<62> Microbial Limit Tests for Tablet and Capsule FormsUSP <62> Tests for Specified Microorganisms in Non-Sterile ProductsUSP <71> Sterility Testing of Injectable Pharmaceutical Products

Comprehensive Guide to ISO 21149 Enumeration of Aerobic Mesophilic Bacteria in Cosmetic and Pharma Laboratory Testing Service Provided by Eurolab

The ISO 21149 standard is a widely recognized international standard for the enumeration of aerobic mesophilic bacteria in cosmetic and pharma products. This standard is developed and published by the International Organization for Standardization (ISO), which is responsible for developing and maintaining over 24,000 international standards.

Legal and Regulatory Framework

The ISO 21149 standard is designed to ensure that cosmetic and pharma products meet specific quality and safety requirements. The standard is applicable to all countries that have adopted it, either through national laws or regulations. In the European Union (EU), for example, the standard is part of the Cosmetics Regulation (EC) No 1223/2009, which sets out the requirements for cosmetic products.

International and National Standards

The ISO 21149 standard is an international standard that has been adopted by many countries around the world. In addition to the EU, other countries that have adopted the standard include the United States, Canada, Australia, and Japan. Each country may have its own national standards or regulations that complement or supplement the ISO 21149 standard.

Standard Development Organizations

The ISO 21149 standard is developed and maintained by the ISO Technical Committee (TC) 194, which is responsible for developing standards related to microbiological analysis of cosmetics and pharmaceuticals. The TC 194 is composed of experts from around the world who are knowledgeable in the field of microbiology and cosmetic/pharma testing.

Standard Evolution and Update

Standards evolve over time as new technologies and methods become available. The ISO 21149 standard has undergone several revisions since its initial publication in 2006, with the latest revision being published in 2020. The standard is updated to reflect changes in technology, regulatory requirements, and scientific knowledge.

Standard Numbers and Scope

The ISO 21149 standard has a specific scope that defines the type of tests and analysis required for cosmetic and pharma products. The standard requires the enumeration of aerobic mesophilic bacteria, which are microorganisms that grow best at moderate temperatures (25-37C).

Standard Compliance Requirements

The compliance requirements for the ISO 21149 standard vary depending on the country or region where the product is manufactured or marketed. In general, manufacturers must ensure that their products meet the standards requirements before they can be sold in the market.

Industries and Sectors

The ISO 21149 standard applies to various industries and sectors, including:

  • Cosmetic manufacturers
  • Pharmaceutical companies
  • Personal care product manufacturers
  • Medical device manufacturers
  • Risk Factors and Safety Implications

    Failure to comply with the ISO 21149 standard can have serious safety implications for consumers. Microbiological contamination can lead to infections, allergic reactions, and other health problems.

    Quality Assurance and Quality Control

    The ISO 21149 standard requires manufacturers to implement quality assurance (QA) and quality control (QC) measures to ensure that their products meet the standards requirements. QA measures include procedures for sampling, testing, and validation, while QC measures involve monitoring and controlling the manufacturing process to prevent contamination.

    Why This Test is Needed

    The ISO 21149 standard requires manufacturers to enumerate aerobic mesophilic bacteria in their products because these microorganisms can cause infections, allergic reactions, and other health problems. The standard ensures that manufacturers take steps to minimize the risk of microbiological contamination.

    Business and Technical Reasons for Conducting the Test

    Manufacturers conduct the test to ensure compliance with regulatory requirements, prevent product recalls, and maintain customer confidence in their products.

    Consequences of Not Performing the Test

    Failure to comply with the ISO 21149 standard can result in serious consequences, including:

  • Product recalls
  • Loss of customer confidence
  • Financial penalties
  • Damage to reputation
  • Industries and Sectors That Require This Testing

    The testing is required for various industries and sectors, including cosmetic manufacturers, pharmaceutical companies, personal care product manufacturers, and medical device manufacturers.

    Risk Factors and Safety Implications

    Failure to comply with the ISO 21149 standard can have serious safety implications for consumers, including infections, allergic reactions, and other health problems.

    Quality Assurance and Quality Control Aspects

    The standard requires manufacturers to implement QA and QC measures to ensure that their products meet the standards requirements. QA measures include procedures for sampling, testing, and validation, while QC measures involve monitoring and controlling the manufacturing process to prevent contamination.

    Why This Test Contributes to Product Safety and Reliability

    The test contributes to product safety and reliability by ensuring that manufacturers take steps to minimize the risk of microbiological contamination.

    Competitive Advantages of Having This Testing Performed

    Manufacturers who conduct the testing can enjoy competitive advantages, including:

  • Increased customer confidence
  • Improved reputation
  • Compliance with regulatory requirements
  • The ISO 21149 standard requires manufacturers to use a specific test methodology for enumerating aerobic mesophilic bacteria. The standard specifies the following steps:

    1. Sample preparation: Manufacturers must prepare samples of their products according to the standards requirements.

    2. Incubation: Samples are incubated in a controlled environment (25-37C) for 7 days.

    3. Enumeration: Bacteria are enumerated using a specific method, such as the plate count technique.

    Test Equipment and Materials

    Manufacturers must use specific equipment and materials to conduct the test, including:

  • Microbiological media
  • Incubators
  • Pipettes
  • Data Analysis and Reporting

    Manufacturers must analyze data from the test and report results in a specific format. The standard specifies that results should be expressed as colony-forming units (CFU) per milliliter.

    Test Validation and Calibration

    Manufacturers must validate and calibrate their test equipment and procedures to ensure that they meet the standards requirements.

    In conclusion, the ISO 21149 standard is an essential requirement for cosmetic and pharma manufacturers who want to ensure compliance with regulatory requirements and maintain customer confidence in their products. Manufacturers must implement QA and QC measures, conduct regular testing, and use specific test equipment and materials to meet the standards requirements.

    Eurolab is a leading laboratory testing service provider that offers comprehensive microbiological testing services for cosmetic and pharma manufacturers. Our experts are experienced in conducting tests according to the ISO 21149 standard, including:

  • Enumeration of aerobic mesophilic bacteria
  • Identification of microorganisms
  • Detection of microbial contaminants
  • Benefits of Choosing Eurolabs Services

    Manufacturers who choose Eurolabs services can enjoy several benefits, including:

  • Compliance with regulatory requirements
  • Improved product safety and reliability
  • Increased customer confidence
  • Cost savings through efficient testing procedures
  • In conclusion, the ISO 21149 standard is an essential requirement for cosmetic and pharma manufacturers who want to ensure compliance with regulatory requirements and maintain customer confidence in their products. Eurolabs comprehensive testing services can help manufacturers meet the standards requirements and improve product safety and reliability.

    Please note that this guide provides a general overview of the ISO 21149 standard and its requirements. Manufacturers should consult the standard itself for detailed information on test methodology, equipment, and materials required to meet the standards requirements.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    Latest News

    View all

    JOIN US
    Want to make a difference?

    Careers